{"version":"1.0","type":"link","title":"Efficacy and Safety of Glofitamab Plus Polatuzumab Vedotin in Relapsed/Refractory Large B-Cell Lymphoma Including High-Grade B-Cell Lymphoma: Results From a Phase Ib/II Trial.","author_name":"Hutchings M 외","author_url":"https://prs-insight.online/author/Hutchings%20M","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/164487","thumbnail_width":1200,"thumbnail_height":630}